This HTML5 document contains 51 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n17http://linked.opendata.cz/resource/drugbank/drug/DB03172/identifier/drugbank/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/mesh/concept/
n16http://linked.opendata.cz/resource/drugbank/drug/DB03172/identifier/chebi/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n9http://linked.opendata.cz/resource/drugbank/drug/DB03172/identifier/pharmgkb/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n11http://linked.opendata.cz/ontology/mesh/
n14http://linked.opendata.cz/resource/drugbank/drug/DB03172/identifier/pdb/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n15http://linked.opendata.cz/resource/drugbank/drug/DB03172/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB03172/identifier/pubchem-substance/

Statements

Subject Item
n2:DB03172
rdf:type
n3:Drug
n3:description
An antibiotic purine ribonucleoside that readily substitutes for adenosine in the biological system, but its incorporation into DNA and RNA has an inhibitory effect on the metabolism of these nucleic acids. [PubChem]
n3:generalReferences
# Zimmerman TP, Wolberg G, Duncan GS: Metabolism of tubercidin and formycin to their 3':5'-cyclic nucleotides in mammalian cells. J Biol Chem. 1978 Dec 25;253(24):8792-7. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/721814
n3:group
experimental
owl:sameAs
n7:DB03172 n10:DB03172
dcterms:title
Tubercidin
adms:identifier
n9:PA152530738 n13:46505938 n14:TBN n15:46936593 n16:48267 n17:DB03172
n3:synonym
7-Deazadenosine Tubercidine TBN 7-deazaadenosine Sparsomycin A Toyocamycin
n3:synthesisReference
Charles G. Smith, "Tubercidin preparation." U.S. Patent US4065556, issued December 27, 1977.
n11:hasConcept
n12:M0022097
n3:IUPAC-Name
n4:271B55E1-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B55E7-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B55E6-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B55E3-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B55E4-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B55E5-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B55DF-363D-11E5-9242-09173F13E4C5 n4:271B55F7-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B55DD-363D-11E5-9242-09173F13E4C5 n4:271B55E0-363D-11E5-9242-09173F13E4C5 n4:271B55F8-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B55DE-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B55ED-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B55EE-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B55E8-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B55E9-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B55EB-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B55EA-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B55EC-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
69-33-0
n3:category
n3:Bioavailability
n4:271B55F3-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B55F5-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B55F6-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B55F2-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B55F1-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B55F4-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B55E2-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B55EF-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B55F0-363D-11E5-9242-09173F13E4C5